TerrAscend (OTC: TRSSF)
Key Data Points
TerrAscend Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
TerrAscend Company Info
TerrAscend Corp. produces and sells medical cannabis products. The firm owns several businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections and Arise Bioscience Inc. The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.
News & Analysis
Which Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?
Cannabis stocks are back in style, but is either one of these multi-state operators a long-term buy?
This Will Be a Big Test for the Cannabis Industry
Could a multi-state operator finally list on a top North American exchange?
TerrAscend Turns Its First Profit as Revenues Rise
SG&A spending helped with those gains.
This Upcoming Marijuana Merger Could Generate Great Returns for Investors
They're not big names in the cannabis sector, but combined, TerrAscend and Gage Cannabis could soon rival the top multistate operators in the country.
These Canadian Cannabis Producers May Benefit From an Israeli Medical Innovation
A first-of-its-kind medical device from a top-10 biotech could change medical cannabis consumption.
These 2 Under-the-Radar Cannabis Companies Are the Most Profitable in the Industry
TerrAscend and Verano's recent results impressed, especially on the bottom line.
TerrAscend Acquiring 3 Pennsylvania Marijuana Dispensaries for $63 Million
The company will pay most of the purchase price in stock.
5 Pot Stocks Making Big Moves on the 50th Anniversary of 4/20
4/20's half-century anniversary comes with a frenzy of activity as cannabis prohibition is rolled back across many U.S. states.
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.